AKRO - Akero Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AKRO is currently covered by 8 analysts with an average price target of $75.27. This is a potential upside of $26.98 (55.87%) from yesterday's end of day stock price of $48.29.

Akero Therapeutics's activity chart (see below) currently has 52 price targets and 74 ratings on display. The stock rating distribution of AKRO is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 60.06% with an average time for these price targets to be met of 343.33 days.

Highest price target for AKRO is $109, Lowest price target is $73, average price target is $67.14.

Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 03-Mar-2025. First documented stock forecast 15-Jul-2019.

Currently out of the existing stock ratings of AKRO, 37 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$75

$25.62 (51.88%)

$72

5 months 18 days ago
(03-Mar-2025)

12/25 (48%)

$29.46 (64.69%)

266

Buy

$109

$59.62 (120.74%)

$42

6 months 21 days ago
(31-Jan-2025)

2/4 (50%)

$54.92 (101.55%)

401

Buy

$73

$23.62 (47.83%)

$56

6 months 24 days ago
(28-Jan-2025)

5/8 (62.5%)

$21.53 (41.83%)

450

Buy

$96

$46.62 (94.41%)

$46

6 months 24 days ago
(28-Jan-2025)

3/6 (50%)

$44.53 (86.52%)

350

Buy

1 years 2 months 1 days ago
(20-Jun-2024)

1/4 (25%)

$29.93 (96.33%)

474

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AKRO (Akero Therapeutics) average time for price targets to be met?

On average it took 343.33 days on average for the stock forecasts to be realized with a an average price target met ratio 60.06

Which analyst has the current highest performing score on AKRO (Akero Therapeutics) with a proven track record?

EDWARD NASH

Which analyst has the current lower performing score on AKRO (Akero Therapeutics) with a proven track record?

PRAKHAR AGRAWAL

Which analyst has the most public recommendations on AKRO (Akero Therapeutics)?

Edward Nash works at CANACCORD and has 5 price targets and 5 ratings on AKRO

Which analyst is the currently most bullish on AKRO (Akero Therapeutics)?

Eliana Merle with highest potential upside - $59.62

Which analyst is the currently most reserved on AKRO (Akero Therapeutics)?

Liisa Bayko with lowest potential downside - -$11.38

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?